Pharmacokinetics of Rocuronium during pediatric cardiovascular surgery

Pharmacokinetics of Rocuronium during pediatric cardiovascular surgery - Pharmacokinetics of Rocuronium during pediatric cardiovascular surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021145

Enrollment

Registered

2016-02-22

Start date

2016-02-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cyanotic and acyanotic children weighing 5 to 10 kg scheduled for elective congenital cardiac surgery using cardiopulmonary bypass.

Exclusion criteria

Exclusion criteria: Patients with comorbidities including neuromuscular abnormality, liver and renal dysfunction.

Design outcomes

Primary

Measure	Time frame
The pharmacokinetics of rocuronium in cyanotic and acyanotic patients during pediatric cardiac surgery using cardiopulmonary bypass.	—

Countries

Japan

Contacts

Public ContactYoshinobu Nakayama

Kyoto Prefectural University of Medicine Department of Anesthesiology

na-yoshi@koto.kpu-m.ac.jp075-251-5633

Outcome results